Pharmaceutical

Moderna’s mRNA influenza vaccine receives $176m boost

Moderna has received a grant of $176m through the RRPV Consortium to expedite the development of mRNA-based pandemic influenza vaccines.

Jul 4, 2024 - 04:00
Moderna’s mRNA influenza vaccine receives $176m boost
Moderna has received a grant of $176m through the RRPV Consortium to expedite the development of mRNA-based pandemic influenza vaccines.
Read the original article

Tags:

Previous Article

Johnson & Johnson gains FDA and EC approvals for TB treatment

Next Article

Left in limbo: When pharma halts rare disease research

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

SGNB-7H4V by Pfizer for Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer): Likelihood of Approval

SGNB-7H4V by Pfizer for Human Epidermal Growth Factor R...

Jun 20, 2024

STAT+: Senator calls for probe of conflict of interest on federal panel overseeing dietary guidelines

STAT+: Senator calls for probe of conflict of interest ...

Mar 20, 2023

STAT+: As demand for Covid shots wanes, Moderna seeks its next success

STAT+: As demand for Covid shots wanes, Moderna seeks i...

Jun 26, 2023